Naidoo et al. (2003) identified the following potential risk factors for development of osteoporosis in schizophrenia patients:

Factors due to schizophrenia itself

• Poor diet
• Limited weight-bearing exercise
• Smoking
• Polydipsia

Factors due to antipsychotic treatment

• Hyperprolactinemia
• Secondary lowered oestrogen
• Secondary lowered testosterone

Other factors influencing risk of fracture

• Sedation
• Orthostatic hypotension
• Dizziness
• Postmenopausal status
• Anticonvulsants
• Corticosteroids

Ref: - Naidoo, U., Goff, D.C. & Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 (suppl 2), 97-108.

Naidoo et al. (2003) identified the following potential risk factors for development of osteoporosis in schizophrenia patients:

Factors due to schizophrenia itself

• Poor diet
• Limited weight-bearing exercise
• Smoking
• Polydipsia

Factors due to antipsychotic treatment

• Hyperprolactinemia
• Secondary lowered oestrogen
• Secondary lowered testosterone

Other factors influencing risk of fracture

• Sedation
• Orthostatic hypotension
• Dizziness
• Postmenopausal status
• Anticonvulsants
• Corticosteroids

Ref: - Naidoo, U., Goff, D.C. & Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 (suppl 2), 97-108.

Naidoo et al. (2003) identified the following potential risk factors for development of osteoporosis in schizophrenia patients:

Factors due to schizophrenia itself

• Poor diet
• Limited weight-bearing exercise
• Smoking
• Polydipsia

Factors due to antipsychotic treatment

• Hyperprolactinemia
• Secondary lowered oestrogen
• Secondary lowered testosterone

Other factors influencing risk of fracture

• Sedation
• Orthostatic hypotension
• Dizziness
• Postmenopausal status
• Anticonvulsants
• Corticosteroids

Ref: - Naidoo, U., Goff, D.C. & Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 (suppl 2), 97-108.

Naidoo et al. (2003) identified the following potential risk factors for development of osteoporosis in schizophrenia patients:

Factors due to schizophrenia itself

• Poor diet
• Limited weight-bearing exercise
• Smoking
• Polydipsia

Factors due to antipsychotic treatment

• Hyperprolactinemia
• Secondary lowered oestrogen
• Secondary lowered testosterone

Other factors influencing risk of fracture

• Sedation
• Orthostatic hypotension
• Dizziness
• Postmenopausal status
• Anticonvulsants
• Corticosteroids

Ref: - Naidoo, U., Goff, D.C. & Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 (suppl 2), 97-108.

Naidoo et al. (2003) identified the following potential risk factors for development of osteoporosis in schizophrenia patients:

Factors due to schizophrenia itself

• Poor diet
• Limited weight-bearing exercise
• Smoking
• Polydipsia

Factors due to antipsychotic treatment

• Hyperprolactinemia
• Secondary lowered oestrogen
• Secondary lowered testosterone

Other factors influencing risk of fracture

• Sedation
• Orthostatic hypotension
• Dizziness
• Postmenopausal status
• Anticonvulsants
• Corticosteroids

Ref: - Naidoo, U., Goff, D.C. & Klibanski, A. (2003) Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents. Psychoneuroendocrinology, 28 (suppl 2), 97-108.